NAS:BXRX (USA)
Baudax Bio Inc $ 1.30 -0.03 (-2.26%)
Volume:
3,245,431
Avg Vol (1m):
3,885,296
Market Cap $:
55.43 Mil
Enterprise Value $:
40.11 Mil
P/E (TTM):
0.00
P/B:
0.00
Financial Strength | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 2.65 | ||
| Equity-to-Asset | -0.74 | ||
| Debt-to-Equity | -0.21 | ||
| Debt-to-EBITDA | -0.2 | ||
| Altman Z-Score | -5.23 | ||
| WACC vs ROIC | |||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -11481.06 | ||
| Net Margin % | -15919.18 | ||
| ROA % | -110.16 | ||
| ROC (Joel Greenblatt) % | -875.66 |
BXRX
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PS Ratio | 54.17 | ||
| EV-to-EBIT | -0.86 | ||
| EV-to-EBITDA | -0.89 | ||
| EV-to-Revenue | 96.19 | ||
| Current Ratio | 1.45 | ||
| Quick Ratio | 1.36 | ||
| Days Inventory | 389.08 | ||
| Days Sales Outstanding | 334.36 | ||
| Days Payable | 546.58 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History |
|---|
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Earnings Yield (Greenblatt) % | -120 |